Search for stocks /

India Pesticides Ltd Q1 FY26 Concall Decoded: Paddy Season, PEDA Power & Hamirpur Dreams


1. Opening Hook

This quarter, IPL wasn’t about Virat Kohli or Rohit Sharma — it was about Pretilachlor and PEDA. India Pesticides pulled off a 26% revenue jump, 79% PAT growth, and still had the audacity to say, “Don’t worry, US tariffs won’t touch us.” Oh, and their new Hamirpur site is expected to churn ₹1,000 crore revenue in 3–4 years — because why stop at pesticides when you can dream like Ambani. Stick around — this call had exports, backward integration, forex gains, and even a Krishna Janmashtami shoutout.


2. At a Glance

  • Revenue up 25.8% – Farmers ordered more sprays than Swiggy orders in monsoon.
  • EBITDA ₹52 cr, up 62.6% – CFO finally cracked a smile wider than pesticide margins.
  • EBITDA margin 18.4% – Agrochemicals playing FMCG cosplay.
  • PAT ₹35 cr, up 79.2% – Profits multiplied faster than mosquitoes in July.
  • Exports ₹87 cr, Domestic ₹188 cr – India still loves pesticides more than it loves cricket.
  • Capex ₹116 cr – Hamirpur site dreams of ₹1,000 cr turnover, someday.

3. Management’s Key Commentary

“We commissioned expanded PEDA intermediate capacity.”
(Translation: Finally making Pretilachlor in-house instead of importing it like lazy teenagers ordering Maggi.)

“Revenue target is ₹1,000 cr for FY26 with 18–20% margins.”
(Translation: Please write this in bold, we want it trending on FinTwit.)

“US tariffs won’t affect us.”
(Translation: We barely sell there — 3% exports, niche products. Relax, America doesn’t even know our name.)

“PEDA + Pretilachlor sales can hit ₹250–300 cr next year.”
(Translation: Our entire rice herbicide play is now basically GST collection from paddy fields.)

“Hamirpur site will eventually do ₹1,000+ cr turnover.”
(Translation: Trust us — in 3–4 years, this site will look like Disneyland for agrochemicals.)

“Backward integration improved margins.”
(Translation: Why pay imports when you can cook your own masala cheaper?)


4. Numbers Decoded

Source table
MetricQ1 FY26YoY ChangeOne-Line Analysis
Revenue – The Hero₹282 cr+25.8%Monsoon demand + capacity = bumper show.
EBITDA – The Margin Muscle₹52 cr+62.6%
Continue reading with a premium membership.
Become a member
error: Content is protected !!